Gergis U - Search Results

1

Endemic or regionally limited bacterial and viral infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review.

Muhsen IN, Galeano S, Niederwieser D, Koh MBC, Ljungman P, Machado CM, Kharfan-Dabaja MA, de la Camara R, Kodera Y, Szer J, Rasheed W, Cesaro S, Hashmi SK, Seber A, Atsuta Y, Saleh MFM, Srivastava A, Styczynski J, Alrajhi A, Almaghrabi R, Abid MB, Chemaly RF, Gergis U, Brissot E, El Fakih R, Riches M, Mikulska M, Worel N, Weisdorf D, Greinix H, Cordonnier C, Aljurf M. Muhsen IN, et al. Among authors: gergis u. Lancet Haematol. 2023 Apr;10(4):e284-e294. doi: 10.1016/S2352-3026(23)00032-7. Lancet Haematol. 2023. PMID: 36990623 Review.

2

Autologous stem cell transplant in human immunodeficiency virus-positive patients with lymphoid malignancies: focus on infectious complications.

Morawa E, Martin P, Gergis U, van Besien K, Shore T. Morawa E, et al. Among authors: gergis u. Leuk Lymphoma. 2013 Apr;54(4):885-8. doi: 10.3109/10428194.2012.721543. Epub 2012 Sep 8. Leuk Lymphoma. 2013. PMID: 22897727 No abstract available.

3

Effectiveness and safety of tocilizumab, an anti-interleukin-6 receptor monoclonal antibody, in a patient with refractory GI graft-versus-host disease.

Gergis U, Arnason J, Yantiss R, Shore T, Wissa U, Feldman E, Woodworth T. Gergis U, et al. J Clin Oncol. 2010 Oct 20;28(30):e602-4. doi: 10.1200/JCO.2010.29.1682. Epub 2010 Aug 16. J Clin Oncol. 2010. PMID: 20713858 No abstract available.

4

The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological Malignancies.

Choe HK, Gergis U, Mayer SA, Nagar H, Phillips AA, Shore TB, Smith MJ, van Besien K. Choe HK, et al. Among authors: gergis u. Transplantation. 2017 Jan;101(1):e34-e38. doi: 10.1097/TP.0000000000001538. Transplantation. 2017. PMID: 27764032

5

A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma.

Mark TM, Guarneri D, Forsberg P, Rossi A, Pearse R, Perry A, Pekle K, Tegnestam L, Greenberg J, Shore T, Gergis U, Mayer S, Van Besien K, Ely S, Jayabalan D, Sherbenou D, Coleman M, Niesvizky R. Mark TM, et al. Among authors: gergis u. Biol Blood Marrow Transplant. 2017 Jun;23(6):930-937. doi: 10.1016/j.bbmt.2017.03.007. Epub 2017 Mar 8. Biol Blood Marrow Transplant. 2017. PMID: 28285081 Free article. Clinical Trial.

6

A strategy to reduce donor-specific HLA Abs before allogeneic transplantation.

Gergis U, Mayer S, Gordon B, Mark T, Pearse R, Shore T, Van Besien K. Gergis U, et al. Bone Marrow Transplant. 2014 May;49(5):722-4. doi: 10.1038/bmt.2014.11. Epub 2014 Feb 17. Bone Marrow Transplant. 2014. PMID: 24535131 No abstract available.

7

Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML.

Scandura JM, Roboz GJ, Moh M, Morawa E, Brenet F, Bose JR, Villegas L, Gergis US, Mayer SA, Ippoliti CM, Curcio TJ, Ritchie EK, Feldman EJ. Scandura JM, et al. Blood. 2011 Aug 11;118(6):1472-80. doi: 10.1182/blood-2010-11-320093. Epub 2011 May 25. Blood. 2011. PMID: 21613261 Free PMC article. Clinical Trial.

8

Eosinophilic fasciitis as a paraneoplastic syndrome, a case report and review of the literature.

Haddad H, Sundaram S, Magro C, Gergis U. Haddad H, et al. Among authors: gergis u. Hematol Oncol Stem Cell Ther. 2014 Jun;7(2):90-2. doi: 10.1016/j.hemonc.2013.12.003. Epub 2014 Feb 10. Hematol Oncol Stem Cell Ther. 2014. PMID: 24525268 Free article. Review.

9

Autologous stem cell transplant is feasible in very elderly patients with lymphoma and limited comorbidity.

Elstrom RL, Martin P, Hurtado Rua S, Shore TB, Furman RR, Ruan J, Pearse RN, Coleman M, Mark T, Leonard JP, Gergis U. Elstrom RL, et al. Among authors: gergis u. Am J Hematol. 2012 Apr;87(4):433-5. doi: 10.1002/ajh.23108. Epub 2012 Feb 24. Am J Hematol. 2012. PMID: 22367772 Free article. No abstract available.

10

Poor graft function after T cell-depleted allogeneic hematopoietic stem cell transplant.

Reich-Slotky R, Al-Mulla N, Hafez R, Segovia-Gomez J, Goel R, Mayer S, Phillips A, Shore TB, Jing-Mei H, Hsu YS, Vasovic LV, Cushing MM, Gergis U. Reich-Slotky R, et al. Among authors: gergis u. Leuk Lymphoma. 2020 Dec;61(12):2894-2899. doi: 10.1080/10428194.2020.1789622. Epub 2020 Jul 14. Leuk Lymphoma. 2020. PMID: 32662694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page